Brian P. Lee
Instructor
Boston University Chobanian & Avedisian School of Medicine
Neurology

MD, University of California, San Diego


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Zhang TP, Dodge JL, Terrault NA, Lee BP. Differential gastrointestinal mortality in Native Hawaiian/Pacific Islander and Asian subgroups in the U.S.: a cross-sectional analysis of national mortality surveillance data 2018-2023. Lancet Reg Health Am. 2026 Mar; 55:101372. PMID: 41586380; PMCID: PMC12829122; DOI: 10.1016/j.lana.2026.101372;
     
  2. Su Y, Dodge JL, Lee BP. Reply to 'Bridging Association to Action: Reframing Environmental Exposure Assessment in PCE-Linked Liver Fibrosis'. Liver Int. 2026 Jan; 46(1):e70462. PMID: 41376263
     
  3. Brar G, Lee BP. Association of Cirrhosis Etiology With Outcomes after Transjugular Intrahepatic Portosystemic Shunt: A National Cohort Study. Gastro Hep Adv. 2026; 5(2):100850. PMID: 41537124; PMCID: PMC12796001; DOI: 10.1016/j.gastha.2025.100850;
     
  4. Su Y, Dodge JL, Lee BP. Tetrachloroethylene Is Associated With Presence of Significant Liver Fibrosis: A National Cross-Sectional Study in US Adults. Liver Int. 2025 Nov; 45(11):e70398. PMID: 41098099
     
  5. Diaz LA, Thiele M, Louvet A, Lee BP, Ajmera V, Tavaglione F, Hsu CL, Huang DQ, Pose E, Bataller R, McClain C, Mellinger J, Tincopa M, Mitchell MC, Ratziu V, Rinella ME, Sarin SK, Shah VH, Szabo G, Wong VW, Bansal MB, Leggio L, Kamath PS, Krag A, Sanyal AJ, Arrese M, Arab JP, Anstee QM, Mathurin P, Loomba R. Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease. Nat Rev Gastroenterol Hepatol. 2025 Dec; 22(12):866-884. PMID: 41006824
     
  6. Hodara E, Dodge JL, Terrault NA, Lee BP. Cardiometabolic risk factors and alcohol use among adults aged 20-25: A nationally representative US study. J Hepatol. 2026 Jan; 84(1):e16-e18. PMID: 40849044
     
  7. Congly SE, Lee BP, Im GY, Simonetto DA, Diaz LA, Arab JP. Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease. Clin Gastroenterol Hepatol. 2026 Feb; 24(2):569-571. PMID: 40714384
     
  8. Gopalkrishnan K, Dodge JL, Lee BP. Significant Liver Disease Among Increased Alcohol Consumers More Than Doubled From 1999 to 2020 Alongside Evolving US Population Demographics. Clin Gastroenterol Hepatol. 2026 Feb; 24(2):566-568.e2. PMID: 40712716; PMCID: PMC12327805; DOI: 10.1016/j.cgh.2025.07.006;
     
  9. Orandi BJ, Chen Y, Li Y, Charytan D, Lentine KL, Lee BP, Ali N, DeMarco MP, Weintraub MA, Bae S, Lonze BE, Ren-Fielding CJ, Lofton H, Gujral A, Segev DL, McAdams-DeMarco M. GLP-1 Receptor Agonist Outcomes, Safety, and Body Mass Index Change in a National Cohort of Patients on Dialysis. Clin J Am Soc Nephrol. 2025 Jun 17; 20(8):1100-1110. PMID: 40526425; PMCID: PMC12342107; DOI: 10.2215/CJN.0000000750;
     
  10. Lee BP. Acamprosate for the Treatment of Alcohol Dependence With Liver Disease. Mayo Clin Proc. 2025 May 07. PMID: 40455192
     
Showing 10 of 65 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 65 publications over 9 distinct years, with a maximum of 16 publications in 2025

YearPublications
20181
20196
20204
20214
20229
20239
202414
202516
20262

Contact for Mentoring:
Lee's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department